Aligos Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Aligos Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2018 to Q4 2023.
  • Aligos Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $99K, a 96.8% decline year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $99K -$3M -96.8% Dec 31, 2023 10-K 2024-03-12
Q4 2022 $3.1M +$659K +27% Dec 31, 2022 10-K 2024-03-12
Q4 2021 $2.44M +$905K +58.9% Dec 31, 2021 10-K 2024-03-12
Q4 2020 $1.54M +$899K +141% Dec 31, 2020 10-K 2023-03-09
Q4 2019 $637K +$558K +706% Dec 31, 2019 10-K 2022-03-10
Q4 2018 $79K Dec 31, 2018 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.